Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Papamichail

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Anticancer Research|November 1, 1996
Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parametersG P Stathopoulos, C N Baxevanis, N G Papadopoulos, et al.
Mutation Research|November 16, 1992
Sister-chromatid exchange in highly purified human CD4+ and CD8+ lymphocytesC Sarri, C N Baxevanis, G B Côté, et al.
Journal of Biological Regulators and Homeostatic Agents|February 25, 2003
Intracellular detection of Bcl-2 and p53 proteins by flow cytometry: comparison of monoclonal antibodies and sample preparation protocolsL Zamai, B Canonico, A Gritzapis, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2000
Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymphocytes against autologous human carcinomasI F Voutsas, C N Baxevanis, A D Gritzapis, et al.
Anticancer Research|March 1, 1992
Monocyte disorders associated with T cell defects in patients with solid tumorsE Anastasopoulos, G J Reclos, C N Baxevanis, et al.
Natural Immunity|January 1, 1993
Comparison of immune parameters in patients with one or two primary malignant neoplasmsC N Baxevanis, G J Reclos, A D Gritzapis, et al.
Immunopharmacology and Immunotoxicology|September 15, 1998
Mistletoe lectin I-induced effects on human cytotoxic lymphocytes. I. Synergism with IL-2 in the induction of enhanced LAK cytotoxicityC N Baxevanis, I F Voutsas, M H Soler, et al.
Atherosclerosis|June 24, 2003
High prevalence of Chlamydia pneumoniae antibodies in white-coat hypertensivesVassiliki C Pitiriga, Vasilios T Kotsis, Christos M Papamichail, et al.
American Journal of Hypertension|August 29, 2003
Chlamydia pneumoniae and Epstein-Barr antibodies are not associated with carotid thickness: the effect of hypertensionVassiliki C Pitiriga, Vasilios T Kotsis, Vassiliki Gennimata, et al.
British Journal of Cancer|November 27, 2001
Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitopeR Sotiriadou, S A Perez, A D Gritzapis, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Anticancer Research|November 1, 1996
Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parametersG P Stathopoulos, C N Baxevanis, N G Papadopoulos, et al.
Mutation Research|November 16, 1992
Sister-chromatid exchange in highly purified human CD4+ and CD8+ lymphocytesC Sarri, C N Baxevanis, G B Côté, et al.
Journal of Biological Regulators and Homeostatic Agents|February 25, 2003
Intracellular detection of Bcl-2 and p53 proteins by flow cytometry: comparison of monoclonal antibodies and sample preparation protocolsL Zamai, B Canonico, A Gritzapis, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2000
Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymphocytes against autologous human carcinomasI F Voutsas, C N Baxevanis, A D Gritzapis, et al.
Anticancer Research|March 1, 1992
Monocyte disorders associated with T cell defects in patients with solid tumorsE Anastasopoulos, G J Reclos, C N Baxevanis, et al.
Natural Immunity|January 1, 1993
Comparison of immune parameters in patients with one or two primary malignant neoplasmsC N Baxevanis, G J Reclos, A D Gritzapis, et al.
Immunopharmacology and Immunotoxicology|September 15, 1998
Mistletoe lectin I-induced effects on human cytotoxic lymphocytes. I. Synergism with IL-2 in the induction of enhanced LAK cytotoxicityC N Baxevanis, I F Voutsas, M H Soler, et al.
Atherosclerosis|June 24, 2003
High prevalence of Chlamydia pneumoniae antibodies in white-coat hypertensivesVassiliki C Pitiriga, Vasilios T Kotsis, Christos M Papamichail, et al.
American Journal of Hypertension|August 29, 2003
Chlamydia pneumoniae and Epstein-Barr antibodies are not associated with carotid thickness: the effect of hypertensionVassiliki C Pitiriga, Vasilios T Kotsis, Vassiliki Gennimata, et al.
British Journal of Cancer|November 27, 2001
Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitopeR Sotiriadou, S A Perez, A D Gritzapis, et al.
Pageof 12